Katia Falasca
- Virology top 5%
- HIV Research and Treatment 11
- Hepatology top 5%
- Hepatitis C virus research 11
- Emergency Medicine top 2%
- HIV-related health complications and treatments 22
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 13
- HIV/AIDS drug development and treatment 12
- SARS-CoV-2 and COVID-19 Research 7
- Epidemiology top 10%
- Hepatitis B Virus Studies 6
-
- Long-Term Effects of COVID-19 8
- Co-authors
- Jacopo VecchietClaudio UcciferriEligio PizzigalloPaola MancinoMarta Di NicolaPio ContiFrancesco CipolloneMargherita D’Alessandro
- Cited by
- VirologyHepatologyEmergency Medicine
- Journals
- SHILAP Revista de lepidopterología (4 papers)PLoS ONE (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ItalyUnited StatesGreece
In The Last Decade
Katia Falasca
87 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 115
- Virology 165
- Hepatology 200
- Emergency Medicine 241
- Infectious Diseases 421
- Epidemiology 389
Countries citing papers authored by Katia Falasca
This map shows the geographic impact of Katia Falasca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Falasca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Falasca more than expected).
Fields of papers citing papers by Katia Falasca
This network shows the impact of papers produced by Katia Falasca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Falasca. The network helps show where Katia Falasca may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katia Falasca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 11 | |
| 12 | The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile | 2020 | 1 |
| 13 | 2020 | 17 | |
| 14 | 2018 | 6 | |
| 15 | 2017 | 15 | |
| 16 | 2016 | 21 | |
| 17 | Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. | 2012 | 20 |
| 18 | Proteinuria in an African HIV-infected patient: effects of telmisartan. | 2011 | 1 |
| 19 | 2010 | 3 | |
| 20 | Acute urinary retention due to HSV-1: a case report. | 2009 | 4 |
About Katia Falasca
Katia Falasca is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 92 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (22 papers), COVID-19 Clinical Research Studies (13 papers), HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers), Hepatitis C virus research (11 papers), Long-Term Effects of COVID-19 (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Virology (165 citations), Hepatology (200 citations) and Emergency Medicine (241 citations). Katia Falasca has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Jacopo Vecchiet, Claudio Ucciferri, Eligio Pizzigallo, Paola Mancino, Marta Di Nicola, Pio Conti, Francesco Cipollone, Margherita D’Alessandro, Claudia Petrarca and Marcella Reale. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.